Skip to the page

Data / Drug companies / Melaleuca Inc.

Melaleuca Inc.: 53 products in the FDA NDC directory, labeler code 54473

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Melaleuca Inc. (labeler code 54473) lists 53 products in the FDA National Drug Code Directory, covering 29 finished drugs by generic name. By type: 53 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 1, 2025.

The request: Watch Melaleuca Inc. (FDA labeler code 54473): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
54473
Products in commercial distribution
53
Packages
56
Finished drugs by generic name
29
Prescription products
0
Over the counter products
53
Flagged as original packager
53 of 53 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
July 1, 1995
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs5196.2%
Generic drugs (ANDA)23.8%

Products by type

TypeProductsShare
Over the counter drugs53100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Titanium dioxide 5% and zinc oxide 5%101
Avobenzone 2.5%, octinoxate 6%, oxybenzone 3%41
Octinoxate 7.5%, titanium dioxide 5%, zinc oxide 1%41
Potassium nitrate and sodium fluoride37
Aluminum zirconium tetrachlorohydrex gly213
Sodium fluoride2124
Menthol2263
Aluminum zirconium trichlorohydrex gly211
Salicylic acid2330
Camphor and menthol and methyl salicylate21
Hydrocortisone1171
Lidocaine1216
230 n12
Clotrimazole198
Bacitracin zinc and neomycin and polymyxin b sulfate11
Diaper rash cream12
Avobenzone, homosalate, octisalate, octocrylene1157
Ethyl alcohol1120
410 n12
Famotidine1138
Acetaminophen1214
Ibuprofen1190
Benzoyl peroxide182
115 n12
Hand sanitizing wipes16
Colloidal oatmeal166
Acetaminophen and diphenhydramine12
Loratadine1125
Octisalate 5%, octocrylene 3%, zinc oxide 10.5%11

Dosage forms

Dosage formProductsShare
Lotion1834%
Cream917%
Stick815.1%
Paste, dentifrice47.5%
Lozenge23.8%
Tablet, coated23.8%
Tablet23.8%
Ointment11.9%
Spray11.9%
Gel11.9%
Tablet, film coated11.9%
Cloth11.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sei Bella Tinted BB Moisturizing Cream54473-408LotionOver the counter monograph drugsMarch 1, 2025
Sei Bella Tinted BB Moisturizing Cream54473-407LotionOver the counter monograph drugsMarch 1, 2025
Sei Bella Tinted BB Moisturizing Cream54473-406LotionOver the counter monograph drugsMarch 1, 2025
Clear Defense54473-409ClothOver the counter monograph drugsJanuary 1, 2025
Sei Bella Daily UV Defense Broad-Spectrum SPF 25 Sunscreen54473-403CreamOver the counter monograph drugsMay 1, 2024
Renew Intensive Skin Therapy Targeted Eczema Treatment54473-410CreamOver the counter monograph drugsJanuary 1, 2024
Clarity Clear Skin Solutions Acne Spot Treatment54473-402CreamOver the counter monograph drugsJanuary 1, 2024
Sei Bella Clarity Clear Refining Foaming Cleanser Acne treatment54473-401LiquidOver the counter monograph drugsJanuary 1, 2024
Sei Bella Clarity Clear Acne All-Over Clearing Serum Cleansing Serum54473-400SoapOver the counter monograph drugsJanuary 1, 2024
CounterAct Allergy54473-166TabletGeneric drugs (ANDA)August 19, 2023
CounterAct IB54473-306Tablet, coatedGeneric drugs (ANDA)August 14, 2023
Sun Shades Lip Balm Cranberry Tangerine54473-223StickOver the counter monograph drugsJanuary 31, 2023
Alloy Antiperspirant and Deodorant54473-339StickOver the counter monograph drugsApril 20, 2022
Affinia Antiperspirant Deodorant Vanilla Musk and Jasmine54473-338StickOver the counter monograph drugsApril 12, 2022
Affinia Antiperspirant Deodorant Sweet Cream and Willow54473-307StickOver the counter monograph drugsApril 12, 2022
Exceed Total Care Sensitive Peppermint Tooth Polish54473-340Paste, dentifriceOver the counter monograph drugsJanuary 8, 2022
Exceed Total Care Sensitive Spearmint Tooth Polish54473-337Paste, dentifriceOver the counter monograph drugsJanuary 8, 2022
Original Pain-A-Trate Pain-Relieving Cream54473-335CreamOver the counter monograph drugsOctober 1, 2021
Ultra Pain-A-Trate Pain-Relieving Cream54473-334CreamOver the counter monograph drugsOctober 1, 2021
Koala Kubs Diaper Rash Cream54473-333CreamOver the counter monograph drugsJuly 9, 2021
HemAway54473-336CreamOver the counter monograph drugsAugust 4, 2020
Sun Shades Sunscreen Sunscreen SPF 5054473-404SprayOver the counter monograph drugsMay 1, 2020
Clear Defense54473-311GelOver the counter monograph drugsMarch 31, 2020
Sei Bella Tinted BB Moisturizing Creme Sheer to Light 140 N54473-310LotionOver the counter monograph drugsMay 1, 2018
Sei Bella Tinted BB Moisturizing Creme Sheer to Light 20 N54473-309LotionOver the counter monograph drugsMay 1, 2018

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.